Further evaluation of the characteristics of Treponema pallidum-specific IgM antibody in syphilis serofast reaction patients.

Further evaluation of the characteristics of Treponema pallidum-specific IgM antibody in syphilis serofast reaction patients.

Item
http://www.wikidata.org/entity/Q44228173
A case series of 130 neonates with congenital syphilis: preterm neonates had more clinical evidences of infection than term neonates.Molecular subtyping of Treponema pallidum and associated factors of serofast status in early syphilis patients: Identified novel genotype and cytokine marker.Factors associated with serological cure and the serofast state of HIV-negative patients with primary, secondary, latent, and tertiary syphilis.Potential Predictors for Serofast State after Treatment among HIV-Negative Persons with Syphilis in China: A Systematic Review and Meta-AnalysisCXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients.Management of Adult Syphilis: Key Questions to Inform the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.Serological Response Predicts Normalization of Cerebrospinal Fluid Abnormalities at Six Months after Treatment in HIV-Negative Neurosyphilis Patients.Analysis of 3 algorithms for syphilis serodiagnosis and implications for clinical management.
P2860

Further evaluation of the characteristics of Treponema pallidum-specific IgM antibody in syphilis serofast reaction patients.

Item
http://www.wikidata.org/entity/Q44228173
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Further evaluation of the char ...... is serofast reaction patients.
@en
Further evaluation of the char ...... is serofast reaction patients.
@nl
type
label
Further evaluation of the char ...... is serofast reaction patients.
@en
Further evaluation of the char ...... is serofast reaction patients.
@nl
prefLabel
Further evaluation of the char ...... is serofast reaction patients.
@en
Further evaluation of the char ...... is serofast reaction patients.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Further evaluation of the char ...... is serofast reaction patients.
@en
P2093
P304
P31
P356
10.1016/J.DIAGMICROBIO.2011.07.005
P433
P478
P577
P698